Boston Scientific (NYSE: BSX) shares ticked up before hours today on second-quarter results that came in ahead of the consensus forecast.

For the third quarter, the stent maker forecast earnings in a range between 44 cents and 46 cents a share on sales growth of about 17%-to-19%. On an adjusted basis, Boston Sci targeted earnings ...

The hottest hitter in Major League Baseball is also the hottest trade chip on the summer market, and his name is Eugenio ...